Most Read This Week
- Safety and Efficacy of Intravenous Recombinant Human Prourokinase for Acute Ischaemic Stroke Within 4.5 Hours After Stroke Onset
- Differences in Treatment Outcomes Between Patients With MS Receiving Ocrelizumab and Those Receiving Ofatumumab
- Toward Personalized Dosing of B-Cell–Depleting Therapy
- Hypogammaglobulinemia and Severe Infections in Patients With MS on Anti-CD20 Agents
- Addition of Cilostazol to Antiplatelet Therapy for In-Stent Restenosis After Carotid Artery Stenting
Recently Updated
- Transcutaneous Auricular Vagus Nerve Stimulation Effective for Insomnia
- Neurocognitive Battery Feasible in 3-Year-Olds During Leukemia Treatment
- AI Performs Well in Identifying Infantile Epileptic Spasms
- Team Sports, but Not Overall Physical Activity, in Young Childhood Linked to Later Executive Function
- Antibiotic Use Not Linked to Incident Dementia, Cognitive Impairment